An open‐label, first‐in‐human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma.
Saved in:
| Title: | An open‐label, first‐in‐human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma. |
|---|---|
| Authors: | Kapoor, Prashant1 (AUTHOR), Nathwani, Nitya2 (AUTHOR), Jelinek, Tomas3 (AUTHOR), Pour, Ludek4 (AUTHOR), Perrot, Aurore5 (AUTHOR), Dimopoulos, Meletios‐Athanasios6 (AUTHOR), Huang, Shang‐Yi7 (AUTHOR), Spicka, Ivan8 (AUTHOR), Chhabra, Saurabh9 (AUTHOR), Lichtman, Eben10,11 (AUTHOR), Mateos, Maria‐Victoria12 (AUTHOR), Kanagavel, Dheepak13 (AUTHOR), Zhao, Liang14 (AUTHOR), Guillemin‐Paveau, Helene13 (AUTHOR), Macé, Sandrine13 (AUTHOR), van de Velde, Helgi15 (AUTHOR), Richardson, Paul G.16 (AUTHOR) paul_richardson@dfci.harvard.edu |
| Source: | European Journal of Haematology. Nov2024, Vol. 113 Issue 5, p593-605. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 180089268 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An open‐label, first‐in‐human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Kapoor%2C+Prashant%22">Kapoor, Prashant</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nathwani%2C+Nitya%22">Nathwani, Nitya</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jelinek%2C+Tomas%22">Jelinek, Tomas</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pour%2C+Ludek%22">Pour, Ludek</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Perrot%2C+Aurore%22">Perrot, Aurore</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dimopoulos%2C+Meletios‐Athanasios%22">Dimopoulos, Meletios‐Athanasios</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Shang‐Yi%22">Huang, Shang‐Yi</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Spicka%2C+Ivan%22">Spicka, Ivan</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chhabra%2C+Saurabh%22">Chhabra, Saurabh</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lichtman%2C+Eben%22">Lichtman, Eben</searchLink><relatesTo>10,11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mateos%2C+Maria‐Victoria%22">Mateos, Maria‐Victoria</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kanagavel%2C+Dheepak%22">Kanagavel, Dheepak</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+Liang%22">Zhao, Liang</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guillemin‐Paveau%2C+Helene%22">Guillemin‐Paveau, Helene</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Macé%2C+Sandrine%22">Macé, Sandrine</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+de+Velde%2C+Helgi%22">van de Velde, Helgi</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Richardson%2C+Paul+G%2E%22">Richardson, Paul G.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<i> paul_richardson@dfci.harvard.edu</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Haematology%22">European Journal of Haematology</searchLink>. Nov2024, Vol. 113 Issue 5, p593-605. 13p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=180089268 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/ejh.14270 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 593 Titles: – TitleFull: An open‐label, first‐in‐human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kapoor, Prashant – PersonEntity: Name: NameFull: Nathwani, Nitya – PersonEntity: Name: NameFull: Jelinek, Tomas – PersonEntity: Name: NameFull: Pour, Ludek – PersonEntity: Name: NameFull: Perrot, Aurore – PersonEntity: Name: NameFull: Dimopoulos, Meletios‐Athanasios – PersonEntity: Name: NameFull: Huang, Shang‐Yi – PersonEntity: Name: NameFull: Spicka, Ivan – PersonEntity: Name: NameFull: Chhabra, Saurabh – PersonEntity: Name: NameFull: Lichtman, Eben – PersonEntity: Name: NameFull: Mateos, Maria‐Victoria – PersonEntity: Name: NameFull: Kanagavel, Dheepak – PersonEntity: Name: NameFull: Zhao, Liang – PersonEntity: Name: NameFull: Guillemin‐Paveau, Helene – PersonEntity: Name: NameFull: Macé, Sandrine – PersonEntity: Name: NameFull: van de Velde, Helgi – PersonEntity: Name: NameFull: Richardson, Paul G. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09024441 Numbering: – Type: volume Value: 113 – Type: issue Value: 5 Titles: – TitleFull: European Journal of Haematology Type: main |
| ResultId | 1 |